News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by paulpauper on Friday June 11, 2021 @01:35PM (#27476242)
Worse than that. A drain on public resources for something that does not work. This drug is very expensive.
[ Parent | on HN ]

There are no comments on this comment yet.